Phase II randomized, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).

Shaib, WL; Rupji, M; Khair, TA; Robin, EL; El-Rayes, BF; Huyck, TK; Liu, Y; Sonbol, MB; Bekaii-Saab, TS

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (3):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索